Suppr超能文献

静脉注射45千道尔顿表皮生长因子在大鼠体内的代谢

Metabolism of i.v. administered 45 kDa epidermal growth factor in the rat.

作者信息

Jørgensen P E, Nexø E, Raaberg L, Rasmussen T N, Poulsen S S

机构信息

Department B, University of Copenhagen, Denmark.

出版信息

Regul Pept. 1990 Sep 10;30(2):113-23. doi: 10.1016/0167-0115(90)90052-x.

Abstract

The 45 kDa epidermal growth factor (EGF-(45 kDa)) has been purified from rat urine. We have investigated the distribution and the processing of i.v. injected 125I-labeled EGF-(45 kDa) in the rat. 2.5 min after the i.v. injection only 12% of the label remained in the blood. Most of the label was found in the liver (54%), in the kidneys (7%) and in the skin (4%). The submandibular glands, stomach, small intestine, colon, spleen and lungs contained 1% or less of the radioactivity. Some of the 125I-EGF-(45 kDa) was processed to 125I-EGF-(6 kDa) immunoreactivity in the liver and in the kidneys. The kidneys excreted 125I-EGF-(45 kDa) in the urine, but we were not able to demonstrate 125I-EGF-(6 kDa) in urine. In conclusion, this study shows that homologous EGF-(45 kDa) is cleared from the circulation of rats within a few minutes, mainly by the liver and the kidneys. In vivo both the liver and the kidneys are able to process some of the EGF-(45 kDa) to EGF-(6 kDa) immunoreactivity.

摘要

45 kDa表皮生长因子(EGF-(45 kDa))已从大鼠尿液中纯化出来。我们研究了静脉注射125I标记的EGF-(45 kDa)在大鼠体内的分布及代谢情况。静脉注射后2.5分钟,仅12%的标记物仍留在血液中。大部分标记物存在于肝脏(54%)、肾脏(7%)和皮肤(4%)中。下颌下腺、胃、小肠、结肠、脾脏和肺中的放射性物质含量为1%或更低。部分125I-EGF-(45 kDa)在肝脏和肾脏中被加工成具有125I-EGF-(6 kDa)免疫反应性的物质。肾脏将125I-EGF-(45 kDa)排泄到尿液中,但我们未能在尿液中检测到125I-EGF-(6 kDa)。总之,本研究表明,同源EGF-(45 kDa)在几分钟内就从大鼠循环中清除,主要是通过肝脏和肾脏。在体内,肝脏和肾脏都能够将部分EGF-(45 kDa)加工成具有EGF-(6 kDa)免疫反应性的物质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验